Naftali Kaminski, MD
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Biography
Dr. Naftali Kaminski is, as of July 1st, 2013, the Boehringer-Ingelheim Endowed Professor of Internal Medicine and Chief of Pulmonary, Critical Care and Sleep Medicine, at Yale School of Medicine. Before that he was a tenured professor of Medicine, Pathology, Computational Biology and Human Genetics, and the Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research at the University of Pittsburgh. Dr. Kaminski was the director of the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease and the Lung, Blood and Vascular Center for Genomic Medicine at the division of Pulmonary, Allergy and Critical Care Medicine in University of Pittsburgh. Dr Kaminski received his medical degree from the Hebrew University - Hadassah Medical School in Jerusalem, Israel, and completed a residency in Internal Medicine at Hadassah Mount-Scopus University Hospital in Jerusalem, and a fellowship in pulmonary medicine at Sheba Medical Center in Tel-Hashomer, Israel. Dr Kaminski received his basic science training in Dean Sheppard's laboratory at the Lung Biology Center at UCSF and in functional genomics and microarray technology at the Functional Genomics laboratory at Roche Bioscience, Palo-Alto. After his fellowship in 2000, Dr. Kaminski was appointed head of Functional Genomics at Sheba Medical Center in Israel, before being recruited to head the Simmons Center at the University of Pittsburgh in 2002.
Dr. Kaminski's main research interests involve applying genomic approaches to elucidate basic mechanisms and improve diagnosis and treatment of Idiopathic Pulmonary Fibrosis (IPF), a chronic mostly lethal and currently untreatable scarring lung disease and other chronic lung diseases such Chronic Obstructive Pulmonary Disease (COPD), severe asthma and sarcoidosis. His group pioneered the application of high throughput genome scale transcript profiling in advanced lung disease. Among his key scientific achievements are: The discovery of novel molecules with significant active roles in pulmonary fibrosis, including matrix metalloproteases (MMP7, MMP19) and phosphatases (SHP2, MKP5) , demonstrating that microRNAs, a family of small non-coding RNAs, are differentially expressed in IPF, and that some of them (let-7, mir-29, mir-33) are mechanistically involved in lung fibrosis, and the discovery that the outcome of patients with IPF can be predicted based on the expression of peripheral blood proteins and genes, a finding with practical implication because of the need for risk stratification and transplant prioritization. More recently Dr. Kaminski's team identified a potential antifibrotic role for thyroid hormone signaling, a novel discovery with significant therapeutic implications, and performed single cell RNA sequencing on >300,000 cells obtained from patients with advanced lung disease and created an online freely available data dissemination tool (www.IPFCellAtlas.com). Dr. Kaminski has a strong interest in integrating high throughput ‘omics’ data, such as genome scale DNA variants, coding and non-coding RNAs, microbiome and metabolome information with clinical information to generate systems biology models of lung diseases and to develop precision medicine approaches that are significantly more precise, predictive and patient-centered than anything that is currently available.
Since completing his clinical training, Dr. Kaminski authored more than 340 research papers (including in Nature Medicine, NEJM, Nature Genetics, Nature Communications, PNAS, Science Advances, Science Translational Medicine, Circulation, Lancet Respiratory Medicine, ARCCM and ERJ among others) review articles and book chapters and has given numerous invited talks at national and international conferences, review articles and book chapters and has given numerous invited talks at national and International conferences. Since he finished his fellowship in 2000, Dr. Kaminski has been consistently funded by NIH and is the PI of multiple NIH grants. Dr. Kaminski was a recipient of the Marvin I. Schwarz Award for contributions to patient care and research in pulmonary fibrosis from the Coalition for Pulmonary Fibrosis in 2010 and the University of Pittsburgh Innovator Award in 2012. In 2013, Dr. Kaminski received the American Thoracic Society Recognition of Scientific Achievements award, as well the Helmholtz Institute International Fellow. In 2015 he was elected to the Association of American Physicians. In 2016 he was elected as Fellow of the European Respiratory Society (ERS), and won the European Respiratory Society Gold medal for Interstitial Lung Disease. In 2018, Dr. Kaminski received the Andy Tager Excellence in Mentorship Award from the Respiratory Cell and Molecular Biology Assembly of the American Thoracic Society and was elected fellow of the American Thoracic Society and received the Yale Blavatnik Innovation Award. In 2022 Kaminski received the American Thoracic Society Amberson Lecture award. Dr. Kaminski is active on the ATS and was the editor of “Gene Express”, a column on genomics in the initial days of the ATS Website, a member and chair of the Program Committee of the Assembly on Respiratory Cell and Molecular Biology of the ATS, and member of the ATS Research Advocacy Committee, and Chair of the Assembly on Respiratory, Cell, and Molecular Biology at the American Thoracic Society. He was an associate editor of the American Journal of Respiratory and Critical care Medicine, a member of multiple editorial boards and recently the Deputy Editor of Thorax, BMJ. Dr. Kaminski served as the President of the Association of Pulmonary, Critical Care and Sleep Division Directors in 2019.
Dr. Kaminski is passionate about training physician-scientists for the challenges of 21st century medicine, and especially in the vocabulary, skills and technology of the new fields of genomics, bioinformatics, computational and system biology and their application to understanding the basic mechanisms that govern lung health and disease as well as to designed personalized medicine approaches and has mentored multiple MD and PhD scientists, of them many have productive and well funded independent career. He has most recently recognized for his commitment to mentoring with the American Thoracic Society Andy Tager excellence in mentoring award.
Follow Dr. Kaminski on Twitter @kaminskimed
Follow Dr. Kaminski on mastodon @kaminskimed@med-mastodon.com
<a rel="me" href="https://med-mastodon.com/@Kaminskimed">Mastodon</a>
Education & Training
- MDHebrew University (1989)
- BMHebrew University (1985)
Activities
- "The Single Cell Blueprint of Human Lung Fibrosis"virtual 2022Pulmonary Fibrosis Stakeholder Summit
- "Lessons from the road to #CureIPF"virtual 2022European Pulmonary Fibrosis Patient Summit
- "A man’s view on the role of men in gender equity"virtual, Manitoba, Canada 2022WISDOM (Women In Science: Development, Outreach & Mentoring) EDI Series
- "Cells and Molecular targets the human fibrotic niche"virtual, Cleveland, OH 2022Hot Topics in Inflammation & Immunity: The Profibrotic Cell: Biology and Ontology
- "IPF Pathogenesis"virtual, Ravenna, Italy 2022Transbronchial Cryobiopsy in Diffuse Parenchymal Lung Disease
- "Pulmonary Fibrosis Mechanisms & Therapy"New Haven, CT, United States 2022Student Lecture: PHAR 504 Molecular Mechanisms of Drug Actions
- "Transforming IPF Targets: Turning Towards Epithelial Cells"Boston, MA, United States 20226th Annual IPF Summit
- "The Connectome – High Resolution Lung Atlas"virtual, New Orleans, LA 202215th Annual Countermeasures Against Chemical Threats Network Research Symposium
- "Cell-Based Precision Medicine in Pulmonary Fibrosis: The Future is Now"Keystone, CO 2022Keystone Symposia on Molecular and Cellular Biology
- "Pathogenetic mechanisms of Pulmonary Fibrosis"virtual, Patras, Greece 2022Pulmonary Bridge Congress
- Scientific Symposium, ATS MythBusters: Aging Biology and Cellular Senescence In Chronic Lung Disease - Chicken Or The Egg; "Mythbuster 2: IPF and Cellular Senescence"San Francisco, CA, United States 2022American Thoracic Society International Conference
- Amberson Lecture: "Charting a Road Map to Curing Human Pulmonary Fibrosis"San Francisco, CA, United States 2022American Thoracic Society International Conference
- "Lessons from single cell analysis of IPF"San Francisco, CA, United States 2022Scleroderma Research Foundation Annual Science Workshop
- Postgraduate Course: A Slippery Ladder and a Leaky Pipeline: Gender Equity in Academia; "Gender Equity: The role of men"San Francisco, CA, United States 2022American Thoracic Society International Conference
- "Towards a Single Cell Roadmap to Pulmonary Fibrosis Therapeutics"virtual, Germany 2022DZL Academy Fellows Conference
- "Understanding the forest through the trees – insights from single cell profiling of human lung disease"virtual, Providence, RI 2022Brown Investigators in Respiratory Diseases (BIRDS) Lecture
- "Translating Science into Personalized Care"virtual, Adelaide, Australia 2022TSANZSRS Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science 2022
- "Ready for primetime: Peripheral blood biomarkers in IPF"virtual, Adelaide, Australia 2022TSANZSRS Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science 2022
- "A New Role for an Old Hormone – Thyroid Hormone Agonism in Pulmonary Fibrosis"virtual, Adelaide, Australia 2022TSANZSRS Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science 2022
- "Mapping the road to New Treatments in IPF"Tampa, FL, United States 2022Annual Timothy Ubben Honorary Lecture in Pulmonary Fibrosis
- "Demystifying human advanced lung disease using single cell technologies"virtual, Tokyo, Japan 20224th Symposium on Inflammation Cellular Sociology
- "To Cure Pulmonary Fibrosis We Need a World Map Not a Wordle"virtual, Boston, MA 2022The Inaugural Andrew Tager Lecture on Pulmonary and Critical Care Medicine
- Keynote Speaker: "The Accidental Chief’s Diaries: Notes on genes, careers and communities"virtual, Pittsburgh, PA 2022Fellows & Faculty Research Retreat 2022
- "Pathophysiology of Pulmonary Fibrosis – Lessons from the Human Lung"virtual, Zurich, Switzerland 2022Pathophysiology of Interstitial Lung Diseases Mini-Symposium
- "The Endothelial Cell Atlas of the Lung"Waterville Valley, NH, United States 2021The 2021 Lung Development, Injury and Repair Gordon Research Conference
- "Pulmonary Fibrosis 2021 – an RNA Odyssey"virtual, London, England 2021University College London Respiratory Divisional Lecture Program
- "Lectio Magistralis: IPF pathogenesis"virtual, Milano, Italy 2021Transbronchial Cryobiopsy in Diffuse Parenchymal Lung Disease
- "Pulmonary Fibrosis Mechanisms & Therapy"New Haven, CT, United States 2021Student Lecture: PHAR 504 Molecular Mechanisms of Drug Actions
- "Developing Novel Therapies: Uncovering the PF Connectome"virtual 20215th Annual IPF Summit
- "Stem Cell Signaling in Lung Remodeling"virtual, Burlington, VT 2021Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases
- "Yale clinical trials ramping up, researchers encouraging people to take part"featured in article 2021https://www.wtnh.com/news/health/yale-clinical-trials-ramping-back-up-after-covid-shutdown-researchers-encouraging-people-to-take-part/
- "Cellular changes in pulmonary fibrosis"New Haven, CT, United States 2021Translational Lung Cancer Series
- "From constellations to galaxies - how transcriptomics shapes our understanding of Pulmonary Fibrosis"virtual, Boston, MA 20212021 Gordon Snider Lecture
- "Molecular Networks in IPF"virtual, Boston, MA 2021Second International Conference on Network Medicine and Big Data
- "Precision Medicine in Pulmonary Fibrosis – is it possible?"New Haven, CT, United States 2021Seminar Precision Medicine Interest Group
- "Is human pulmonary fibrosis simply lung regeneration without a blueprint?"virtual 2021ERS Lung Science Conference 2021
- "Dysregulated Cellular Niches in Human Pulmonary Fibrosis"virtual, Los Angeles, CA 2021Hastings Center for Pulmonary Research Symposium
- "Multicellular Understanding of Human Pulmonary Fibrosis"virtual, Sacramento, CA 2021Carroll Cross Distinguished Professorship Series
- "The Pulmonary Fibrosis Single Cell Atlas – Insights and Future plans"virtual, Xinxiang, China 2021Pulmonary Presentation
- "State of the Art Research in Lung Disease: What Really Happens in Human Pulmonary Fibrosis"New Haven, CT, United States 2021Medical Student Course
- "The Single Cell RNA Guide to Pulmonary Fibrosis"virtual, Durham, NC 2020Kaganov Pulmonary Seminar Series
- "Seeing the trees in the forest - Single Cell Analysis of Pulmonary Fibrosis"virtual, New Brunswick, NJ 2020Visiting Professor Lecture Series
- "Understanding Human Pulmonary Fibrosis Using Single Cell Technologies"virtual 2020GenomeWeb Global Webinar
- "The Road to #CureIPF"New Haven, CT, United States 2020Medical Grand Rounds
- "Improving Our Understanding and Treatment of Lung Diseases Using Detailed Atlas of Cellular Changes"virtual, New Haven, CT 202010x Genomics Global Webinar: Single Cell Analysis of Lung Biology
- "Implications of the Insights from the IPF Cell Atlas for Drug Development"virtual 20204th Annual IPF Summit
- Expert Chat: "Big Data and Novel Approaches for Pulmonary, Vascular and Sleep Disorders"virtual 2020American Thoracic Society Virtual Conference
- "Evidence for Role of Mir-29 in the Progression of Pulmonary Fibrosis"virtual 2020Webinar: Development of MRG-229 in IPF
- "Demystifying pulmonary fibrosis with single cell RNA sequencing"virtual 2020Webinar
- How Tear Gas and Pepper Spray Affect the Bodyfeatured in article 2020https://www.healthline.com/health-news/how-tear-gas-and-pepper-spray-affect-the-body
- "Mysteries and non-Mysteries in COVID19 Critical Illness"virtual 2020Broad-ISF Symposium Series
- "Testing Individual Drugs in Humans"New Haven, CT, United States 2020Pharmacology Student Lecture
- "Critical Care in COVID-19 Patients"New Haven, CT, United States 2020Medical Grand Rounds
- ‘Second-week crash’ is time of peril for some covid-19 patientsfeatured in article 2020https://www.washingtonpost.com/health/second-week-crash-is-time-of-peril-for-some-covid-19-patients/2020/04/29/3940fee2-8970-11ea-8ac1-bfb250876b7a_story.html
- YNH Tests Asthma Drug to Treat COVID Complicationfeatured in article 2020https://www.newhavenbiz.com/article/ynh-tests-asthma-drug-to-treat-covid-complication
- "From microarrays to single cell RNAseq - Understanding human pulmonary fibrosis"Bethesda, MD, United States 2020NIH Fibrosis Scientific Interest Group
- A message of hope for the future of IPF treatmentYouTube video 2020https://www.youtube.com/watch?v=EX80815TfGU
- "From Lungs to Single Cells: Using RNA to Demystify Pulmonary Fibrosis"New Haven, CT, United States 2020Pathology Grand Rounds
- "Aging and Pulmonary Fibrosis - common mechanisms and insights from the Human Lung"New Haven, CT, United States 2020Biology of Aging Series Seminar
- The Pulmonology Show with Dr. Frank Adamsradio 2019SiriusXM Doctor Radio
- "Lessons from Single Cell Profiling in Lung Health, Aging and Disease"New Haven, CT, United States 2019Yale Imaging Mass Spectrometry, Omics and Advanced Analytics Symposium
- "Senescence & Fibrosis - Lessons from Transcriptomic Studies of the Human Lung"Washington, DC, United States 2019Telomeres, DNA Damage, Senescence, and Lung Disease Workshop
- "Aberrant and Ectopic Cell Populations in Pulmonary Fibrosis, COPD and Normal Human Lung Aging"Washington, DC, United States 2019Single-cell Omics--A New Frontier in the Research of Heart, Lung, and Blood Diseases and Sleep Disorders Workshop
- "A Frank Discussion About Ending Sexual Harassment in Medicine"podcast 2019The Association of Pulmonary, Critical care, & Sleep Division Directors: From the Trenches Podcast
- "Cells, Pathways, and Genes - on the road to understanding & reversing Pulmonary Fibrosis"Jerusalem, Jerusalem District, Israel 2019Respiratory Grand Rounds
- "Pulmonary Fibrosis 2019 - From Desperate to Hopeful"Jerusalem, Jerusalem District, Israel 2019Department of Medicine Grand Rounds
- "Single Cell Profiling: The New Frontier of Discovery in Advanced Lung Disease"Rome, Lazio, Italy 2019Agostino Gemelli University Hospital IRCCS
- "Making Big Data Accessible to Pulmonary and Critical Care Medicine T32 Trainees"Dallas, TX, United States 2019American Thoracic Society International Conference
- "How to Lead Teams"Dallas, TX, United States 2019American Thoracic Society International Conference
- Postgraduate Course: "Genetics of Interstitial Lung Disease: IPF and Beyond, What to Tell Your Patients and Their Family Members"Dallas, TX, United States 2019American Thoracic Society International Conference
- "Pulmonary Fibrosis, Mechanisms & Therapy"New Haven, CT, United States 20192019 Molecular Mechanisms of Drug Actions - Pharmacology 504a
- "Pulmonary Fibrosis – an RNA centered perspective"Philadelphia, PA, United States 2019Pulmonary Seminar Series
- "#MeToo in Healthcare"podcast 2019The Association of Pulmonary, Critical care, & Sleep Division Directors: From the Trenches Podcast
- "Understanding Pulmonary Fibrosis – Lessons from Single Cells, Disease Microenvironments and Translational Models"Montreal, QC, Canada 201921st Annual Meakins-Christie Laboratories International Workshop
- "Lessons from the Pulmonary Fibrosis Cell Atlas"Washington, DC, United States 2019The Promise of Single Cell and Single Molecule Analysis Tools to Advance Environmental Health Research: A Workshop
- "The RNA guide to Pulmonary Fibrosis – therapeutic targets and mechanistic insights"New Haven, CT, United States 2019Human and Translational Immunology (HTI) Seminar Series
- "Can we cure Pulmonary Fibrosis?"Siena, Tuscany, Italy 2018Universita Degli Studi di Siena Seminario
- "Up-Date on Idiopathic Pulmonary Fibrosis Pathogenesis"Siena, Tuscany, Italy 2018Universita Degli Studi di Siena Seminario
- "Is Pulmonary Fibrosis reversible? Omics Analysis of the lung says yes"Rome, Lazio, Italy 2018Agostino Gemelli University Polyclinic
- "From the Kaminski Lab Diaries: Non-coding RNAs that link senescence and pulmonary fibrosis and hormones that may cure it"New Haven, CT, United States 2018Biomedical Seminar
- Career Development Workshop: Swimming In The Sea Of Big Data For Pulmonary Research: "Case Reports: This Is How We Do It - Examples from the Experts"San Diego, CA, United States 2018American Thoracic Society International Conference
- Interstitial Lung Disease, Idiopathic Interstitial Pneumonia and Hypersensitivity Pneumonitis: Controversies in Management. A Pro/Con Debate: "Serum Biomarkers are Not Useful in the Guiding Diagnosis and Treatment of Idiopathic Interstitial Pneumonia and Hypersensitivity Pneumonitis"San Diego, CA, United States 2018American Thoracic Society International Conference
- Leveraging Molecular Mechanisms of Granuloma Formation in Sarcoidosis to Improve Care: "The Integral Role of Transcriptomics in Disease Manifestations: New Insights from the NHLBI GRADS Study"San Diego, CA, United States 2018American Thoracic Society International Conference
- Research Breakthroughs from NHLBI's Centers for Advanced Diagnostic and Experimental Therapeutics Program: "A Novel Therapeutic Candidate for Idiopathic Pulmonary Fibrosis"San Diego, CA, United States 2018American Thoracic Society International Conference
- Mitochondrial Dysfunction and Reprogramming In Lung Aging And Disease: "Targeting Mitochondrial Dysfunction in Pulmonary Fibrosis to Drive Development of Novel Therapeutics"San Diego, CA, United States 2018American Thoracic Society International Conference
- "Gender Inequality in Academic Medicine"podcast 2018The Association of Pulmonary, Critical care, & Sleep Division Directors: From the Trenches Podcast
- "Sorting Through the Kitchen Sink – Understanding Pulmonary Fibrosis Using RNA"New York, NY, United States 2018Training Grant Retreat
- "Pulmonary Fibrosis – Lessons from the Human Lung"St. Louis, MO, United States 2018Pulmonary and Critical Care Grand Rounds
- "The BAL Transcriptome in Sarcoidosis – Lessons from the GRADS study"Chicago, IL, United States 2018Americas Association of Sarcoidosis and Other Granulomatous Diseases Conference
- "From Desperate to Hopeful – Progress in Pulmonary Fibrosis"Naples, FL, United States 2018Medical Grand Rounds
- "Idiopathic Pulmonary Fibrosis 2018, has it really changed?"Naples, FL, United States 2018Pulmonary Seminar
- "The approach to the patient with ILD"Naples, FL, United States 2018House Staff Conference
- Blood Biomarkers in IPFLondon, England, United Kingdom; Nottingham, England, United Kingdom; Pittsburgh, PA, United States; Boston, MA, United States; Ann Arbor, MI, United States; Chicago, IL, United States 2015Blood Biomarkers in IPF
- Genomic and Microbiome analysis of Sarcoidosis and A1ATDenver, CO, United States; Memphis, TN, United States; Charleston, SC, United States 2015Genomic and Microbiome analysis of Sarcoidosis and A1AT
- Molecular Mechanisms of Lung FibrosisAthens, Attica region, Greece; Charleston, SC, United States; Vancouver, BC, Canada; Leuven, Flanders, Belgium; Munich, BY, Germany 2014Molecular Mechanisms of Lung Fibrosis
- Novel Biomarkers in Bornchoalveolar Lavage of Patients with IPFSiena, Tuscany, Italy; Hanover, NDS, Germany; Leuven, Flanders, Belgium 2013Novel Biomarkers in Bornchoalveolar Lavage of Patients with IPF
Honors & Recognition
Award | Awarding Organization | Date |
---|---|---|
J. Burns Amberson Honorary Award Lecture | American Thoracic Society | 2022 |
Blavatnic Fund Innovation Award | 2019 | |
Andy Tager Excellence in Mentorship Award | The American Thoracic Society Respiratory Cell and Molecular Biology Assembly | 2018 |
Fellow | American Thoracic Society | 2018 |
Fellow | European Respiratory Society | 2016 |
Gold Medal for Interstitial Lung Disease | European Respiratory Society | 2016 |
Member of the Association of American Physicians | 2015 | |
Helmholtz International Fellow Award | Helmholtz Institute | 2013 |
Recognition for Scientific Achievement | American Thoracic Society | 2013 |
Innovator Award | University Of Pittsburgh | 2012 |
Marvin I. Schwarz Research Award | Coalition for Pulmonary Fibrosis | 2010 |
Professional Service
Organization | Role | Date |
---|---|---|
Yale School of Medicine Diversity Supplement Working Group | Member | 2021 - Present |
American Thoracic Society Physician Scientist Forum | Chair | 2019 |
American Thoracic Society Workshop on Single Cell | Co-Chair | 2019 |
LungAging Consortium | Committee Member | 2019 - Present |
Boehringer-Ingelheim Discovery Award | Scientific Committee | 2019 - Present |
Three Lake Partners | Chair of Scientific Advisory Committee | 2019 - Present |
Time Banking System Steering Committee | Member | 2018 - Present |
Yale School of Medicine Admissions Committee | Member | 2018 - Present |
American Thoracic Society | Fellow | 2018 - Present |
Yale School of Medicine Faculty Engagement Committee | Member | 2017 - 2019 |
Faculty Engagement Committee | Co-Chair | 2017 - 2019 |
NIH PSE V 56 | Member | 2017 - 2019 |
Association of Pulmonary, Critical Care and Sleep Division Directors | President | 2017 - 2019 |
Pulmonary Fibrosis Foundation | Board of Directors | 2017 - 2018 |
The Association of Pulmonary, Critical Care, and Sleep Division Directors (APCCSD) Gender Equality Summit | Co-Chair | 2017 |
Yale Center for Biomedical Data Science | Member | 2017 - Present |
Yale School of Public Health Standing Appointments and Advisory Committee (SAAC) | Member | 2017 - Present |
International Colloquium on Lung and Airway Fibrosis | Program Committee | 2017 - Present |
NHLBI R35 SEP | Member | 2016 - 2018 |
American Thoracic Society Respiratory Health Awards Committee | Vice Chair | 2016 - 2018 |
American Thoracic Society Finance Committee | Member | 2016 - 2017 |
European Respiratory Society | Fellow | 2016 - Present |
Thorax BMJ | Editor | 2015 - 2019 |
Research Advisory Forum, Pulmonary Fibrosis Foundation | Member | 2015 - 2019 |
Association of American Physicians | Member | 2015 - Present |
InterUrban Clinical Club | Member | 2015 - Present |
Term Appointments and Promotions Committee, Department of Internal Medicine, Yale School of Medicine | Member | 2014 - 2018 |
Strategic Planning Committee, Yale School of Medicine | Member | 2014 - 2018 |
Clinical & Translational Committee, Department of Internal Medicine | Member | 2014 - 2018 |
American Thoracic Society | Board Member | 2014 - 2018 |
American Thoracic Society Assembly of Respiratory Cell and Molecular Biology | Chair | 2014 - 2016 |
NIH SEP LIRR and RIBT Study Section | Ad-hoc reviewer | 2014 - Present |
Proceedings of the National Academy of Sciences (PNAS) | Guest Editor | 2014 - Present |
NHLBI Proteomics Centers External Advisory Panel | External Reviewer | 2012 |
American Journal of Physiology | Editorial Board Member | 2011 - 2013 |
Pittsburgh International Lung Conference of Personalized Medicine of Lung Disease | Chair | 2011 |
American Journal of Respiratory and Critical Care Medicine | Associate Editor | 2010 - 2015 |
Research Advocacy Committee, American Thoracic Society | Member | 2010 - 2013 |
American Journal of Respiratory Cell and Molecular Biology | Editorial Board Member | 2009 - Present |
NHLBI Study Section, Review RFA’s “Ancillary Studies in Clinical Trials" | Reviewer | 2007 - 2009 |
University of Pittsburgh/Carnegie Mellon University Joint Ph.D. Program | Executive Committee Member | 2006 - 2013 |
Training Program of School of Medicine/PACCM University of Pittsburgh | Executive Committee Member | 2006 - 2013 |
University of Pittsburgh Graduate Faculty Council | Council Member | 2006 - 2013 |
Scientific Advisory Board, Pulmonary Fibrosis Foundation | Member | 2005 - 2018 |
PLoS Medicine | Scientific Consultant | 2005 - 2013 |
American Thoracic Society study section | Ad-hoc reviewer | 2005 - 2008 |
University of Pittsburgh Embryonic Stem Cell Research Oversight (ESCRO) Committee | Committee Member | 2005 - 2006 |
International Colloquium on Pulmonary Fibrosis | Committee Member | 2004 - 2012 |
Genomics and Proteomics Core Laboratories (GPCL) Advisory Board, University of Pittsburgh | Member | 2004 - 2011 |
American Society of Human Genetics | Member | 2004 - 2010 |
NHLBI Review Panel for Clinical Proteomics Programs | Reviewer | 2004 - 2007 |
Middle Eastern Peace Forum of Pittsburgh | Executive Committee Member | 2003 - 2013 |
New England Journal of Medicine | Reviewer | 2002 - Present |
Nature Medicine | Reviewer | 2002 - Present |
Cell | Reviewer | 2002 - Present |
Public Library of Science (PLoS) Medicine | Reviewer | 2002 - Present |
Proceedings of the National Academy of Sciences (PNAS) | Reviewer | 2002 - Present |
Science Translational Medicine | Reviewer | 2002 - Present |
Nature Communications | Reviewer | 2002 - Present |
Journal of Clinical Investigations | Reviewer | 2002 - Present |
American Journal of Respiratory Cell and Molecular Biology | Reviewer | 2002 - Present |
American Journal of Respiratory and Critical Medicine | Reviewer | 2002 - Present |
American Journal of Physiology | Reviewer | 2002 - Present |
New York Academy of Sciences | Member | 1999 - 2001 |
American Society for the Advancement of Science | Member | 1999 - Present |
Israel Society of Pulmonary Medicine | Member | 1994 |
Israel Medical Association | Member | 1989 |
Departments & Organizations
- Center for Biomedical Data Science
- Center for RNA Science and Medicine
- Computational Biology and Biomedical Informatics
- Internal Medicine
- Interstitial Lung Disease (ILD) Program
- Kaminski Lab
- Molecular Medicine, Pharmacology, and Physiology
- Pharmacology
- Pulmonary, Critical Care & Sleep Medicine
- Secondary Faculty
- The Center for Precision Pulmonary Medicine (P2MED)
- Yale Combined Program in the Biological and Biomedical Sciences (BBS)
- Yale Medicine
- Yale Stem Cell Center
- Yale Tissue Regeneration and Fibrosis Program